- call +1-201-465-4211
- email sales@mrinsights.biz
Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal\'s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.
Scope of the Report:
This report focuses on the Anti-Inflammatory Peptides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America has dominated the entire market in 2014, as it has presence of technologically updated systems, strong research & development, and high patient awareness levels in this region. Latin America is also expected to grow at a healthy rate as a result of increase in both private and public associations, causing an increase in the investment, thereby boosting the demand for the anti-inflammatory peptides. However, the Asia Pacific region is expected to witness lucrative growth during the forecast period owing to the rapidly improving healthcare infrastructure in the growing economies of India and China. Growing patient awareness levels among the population of this region coupled with high unmet needs of the patients is expected to further drive this region.
The worldwide market for Anti-Inflammatory Peptides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Mylan Pharmaceuticals
Novartis AG
Rogne Bioscience
Merck Serono
F4 Pharma
Araim Pharmaceuticals, Inc.
Digna Biotech
Abbvie Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cardiovascular Diseases
Gastrointestinal Diseases
Dermatological Diseases
Neurological Diseases
Otorhino Diseases & Ophthalmological
Respiratory Diseases & Pulmonary
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Household
Other
There are 15 Chapters to deeply display the global Anti-Inflammatory Peptides market.
Chapter 1, to describe Anti-Inflammatory Peptides Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Inflammatory Peptides, with sales, revenue, and price of Anti-Inflammatory Peptides, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Inflammatory Peptides, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Inflammatory Peptides market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Inflammatory Peptides sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Inflammatory Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Cardiovascular Diseases
1.2.2 Gastrointestinal Diseases
1.2.3 Dermatological Diseases
1.2.4 Neurological Diseases
1.2.5 Otorhino Diseases & Ophthalmological
1.2.6 Respiratory Diseases & Pulmonary
1.2.7 Renal Diseases
1.2.8 Rheumatological & Autoimmune Diseases
1.2.9 Transplantation
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mylan Pharmaceuticals
2.1.1 Business Overview
2.1.2 Anti-Inflammatory Peptides Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mylan Pharmaceuticals Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Anti-Inflammatory Peptides Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Rogne Bioscience
2.3.1 Business Overview
2.3.2 Anti-Inflammatory Peptides Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Rogne Bioscience Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck Serono
2.4.1 Business Overview
2.4.2 Anti-Inflammatory Peptides Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Serono Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F4 Pharma
2.5.1 Business Overview
2.5.2 Anti-Inflammatory Peptides Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F4 Pharma Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Araim Pharmaceuticals, Inc.
2.6.1 Business Overview
2.6.2 Anti-Inflammatory Peptides Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Araim Pharmaceuticals, Inc. Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Digna Biotech
2.7.1 Business Overview
2.7.2 Anti-Inflammatory Peptides Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Digna Biotech Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Abbvie Corporation
2.8.1 Business Overview
2.8.2 Anti-Inflammatory Peptides Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Abbvie Corporation Anti-Inflammatory Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Inflammatory Peptides Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Inflammatory Peptides Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Inflammatory Peptides Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Inflammatory Peptides Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Inflammatory Peptides Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Inflammatory Peptides Market Analysis by Regions
4.1 Global Anti-Inflammatory Peptides Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Inflammatory Peptides Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Inflammatory Peptides Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
4.5 South America Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
5 North America Anti-Inflammatory Peptides by Countries
5.1 North America Anti-Inflammatory Peptides Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Inflammatory Peptides Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Inflammatory Peptides Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
6 Europe Anti-Inflammatory Peptides by Countries
6.1 Europe Anti-Inflammatory Peptides Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Inflammatory Peptides Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Inflammatory Peptides Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
6.3 UK Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
6.4 France Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Inflammatory Peptides by Countries
7.1 Asia-Pacific Anti-Inflammatory Peptides Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Inflammatory Peptides Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Inflammatory Peptides Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
7.5 India Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
8 South America Anti-Inflammatory Peptides by Countries
8.1 South America Anti-Inflammatory Peptides Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Inflammatory Peptides Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Inflammatory Peptides Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Inflammatory Peptides by Countries
9.1 Middle East and Africa Anti-Inflammatory Peptides Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Inflammatory Peptides Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Inflammatory Peptides Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Inflammatory Peptides Sales and Growth Rate (2013-2018)
10 Global Anti-Inflammatory Peptides Market Segment by Type
10.1 Global Anti-Inflammatory Peptides Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Inflammatory Peptides Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Inflammatory Peptides Revenue and Market Share by Type (2013-2018)
10.2 Cardiovascular Diseases Sales Growth and Price
10.2.1 Global Cardiovascular Diseases Sales Growth (2013-2018)
10.2.2 Global Cardiovascular Diseases Price (2013-2018)
10.3 Gastrointestinal Diseases Sales Growth and Price
10.3.1 Global Gastrointestinal Diseases Sales Growth (2013-2018)
10.3.2 Global Gastrointestinal Diseases Price (2013-2018)
10.4 Dermatological Diseases Sales Growth and Price
10.4.1 Global Dermatological Diseases Sales Growth (2013-2018)
10.4.2 Global Dermatological Diseases Price (2013-2018)
10.5 Neurological Diseases Sales Growth and Price
10.5.1 Global Neurological Diseases Sales Growth (2013-2018)
10.5.2 Global Neurological Diseases Price (2013-2018)
10.6 Otorhino Diseases & Ophthalmological Sales Growth and Price
10.6.1 Global Otorhino Diseases & Ophthalmological Sales Growth (2013-2018)
10.6.2 Global Otorhino Diseases & Ophthalmological Price (2013-2018)
10.7 Respiratory Diseases & Pulmonary Sales Growth and Price
10.7.1 Global Respiratory Diseases & Pulmonary Sales Growth (2013-2018)
10.7.2 Global Respiratory Diseases & Pulmonary Price (2013-2018)
10.8 Renal Diseases Sales Growth and Price
10.8.1 Global Renal Diseases Sales Growth (2013-2018)
10.8.2 Global Renal Diseases Price (2013-2018)
10.9 Rheumatological & Autoimmune Diseases Sales Growth and Price
10.9.1 Global Rheumatological & Autoimmune Diseases Sales Growth (2013-2018)
10.9.2 Global Rheumatological & Autoimmune Diseases Price (2013-2018)
10.10 Transplantation Sales Growth and Price
10.10.1 Global Transplantation Sales Growth (2013-2018)
10.10.2 Global Transplantation Price (2013-2018)
11 Global Anti-Inflammatory Peptides Market Segment by Application
11.1 Global Anti-Inflammatory Peptides Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Household Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anti-Inflammatory Peptides Market Forecast (2018-2023)
12.1 Global Anti-Inflammatory Peptides Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Inflammatory Peptides Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Inflammatory Peptides Market Forecast (2018-2023)
12.2.2 Europe Anti-Inflammatory Peptides Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Inflammatory Peptides Market Forecast (2018-2023)
12.2.4 South America Anti-Inflammatory Peptides Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Inflammatory Peptides Market Forecast (2018-2023)
12.3 Anti-Inflammatory Peptides Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Inflammatory Peptides Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Inflammatory Peptides Market Share Forecast by Type (2018-2023)
12.4 Anti-Inflammatory Peptides Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Inflammatory Peptides Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Inflammatory Peptides Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Inflammatory Peptides Picture
Table Product Specifications of Anti-Inflammatory Peptides
Figure Global Sales Market Share of Anti-Inflammatory Peptides by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
